Neurobiological Technologies, Inc.
OTC: NTII0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- John B. Stuppin
- Employees
- 4
- Headquarters
- EmeryVille, United States
- IPO year
- 1994
- Market cap
- $2.7K
Loading NTII…
Loading profile data…Frequently asked questions about NTII
What does Neurobiological Technologies, Inc. (NTII) do?
Neurobiological Technologies, Inc. (NTII) is currently undergoing a liquidation and dissolution process, a plan that received stockholder endorsement in October 2009. In its earlier operations, the company's core focus was on the development of experimental pharmaceutical treatments for various human ailments. This firm, which was established in...
Where does NTII trade?
Neurobiological Technologies, Inc. (NTII) trades on the Other OTC.
What sector is NTII in?
Neurobiological Technologies, Inc. (NTII) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Neurobiological Technologies, Inc.?
John B. Stuppin is the chief executive officer of Neurobiological Technologies, Inc. (NTII).
Where is Neurobiological Technologies, Inc. headquartered?
Neurobiological Technologies, Inc. is headquartered in United States.
Does NTII pay a dividend?
Neurobiological Technologies, Inc. (NTII) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did NTII go public?
Neurobiological Technologies, Inc. (NTII) completed its initial public offering in 1994.